BBC consultants perform ongoing surveillance of the worldwide IVD Diabetes (Device) Management market, including Whole Blood Glucose (WBG) monitoring, Insulin Infusion Pump (IIP) therapy, Continuous Glucose Monitoring (CGM), along with mobile health technology. The consultants follow technology developments of the major players (Abbott, Ascensia, Dexcom, Insulet, LifeScan, Medtronic and Roche), along with continuing advancements from secondary competitors.

Surveillance of market development activities and dynamics spans across the U.S., EMEA, Asia Pacific, Latin America, and Canada. In total, our consultants monitor more than 20 of the most critical individual country markets in this sector.

We leverage our years of experience to place into context breaking developments—giving our clients a look at tomorrow, today.

We continue to expand our focus with the market’s evolution from WBG Monitoring to mobile health technology

WBG Monitoring
Analysis of ~$6.0B worldwide market, including size, growth and shares across five regions as well as within over 20 country markets.

Analysis of ~$4.0B worldwide market, including Worldwide/U.S./OUS size, growth, and shares of major and secondary players as well as development progress with artificial pancreas technology.

Analysis of ~$2.8B worldwide market, including Worldwide/U.S./OUS size, growth, and shares of major and secondary players), as well as in-depth reviews of select country markets (e.g. U.S., France, Germany, UK, and Canada).

Mobile Health Technology
We recognize and monitor the growing role of mHealth technology for enhancing disease management, including the integration of new players into the field.

BBC provides analysis of emerging players in mobile health technology, including disease management platforms and smart insulin pens and emerging business models driving a sustainable disease management ecosystem.

Strategic Consulting

Beyond the market surveillance offerings, the consultants provide a wealth of strategic consulting services, including assessment of acquisition opportunities, evaluation of product development opportunities, as well as competitive war game scenario planning.

As part of this service, the consultants can collaborate with clients to analyze the vast array of IQVIA prescription and volume data to support strategic decision making.


Advanced Technologies and Treatments for Diabetes (ATTD)
American Association of Diabetes Educators (AADE)
American Diabetes Association (ADA)
Diabetes Technology Meeting (DTM)
European Association for the Study of Diabetes (EASD)